D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

Leading Players Driving Innovation in the Circadian Rhythm Sleep Treatment Market Key players in that circadian rhythm sleep treatment market are Vanda Pharmaceuticals, Inc., Akeda Pharmaceutical ...

Leading Players Driving Innovation in the Circadian Rhythm Sleep Treatment Market Key players in that circadian rhythm sleep treatment market are Vanda Pharmaceuticals, Inc., Akeda Pharmaceutical ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) letter to FDA Commissioner highlights faulty gastroparesis NDA review. Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the U.S. Food ...

With California wildfires triggering a massive rebuilding process that could take several years, investors are looking closer at lumber stocks.

Tradipitant is under clinical development by Vanda Pharmaceuticals and currently in Phase III for Motion Sickness. According to GlobalData, Phase III drugs for Motion Sickness have a 100% phase ...

VHX-896 is under clinical development by Vanda Pharmaceuticals and currently in Phase III for Schizophrenia. According to GlobalData, Phase III drugs for Schizophrenia have a 68% phase transition ...

Also Read: Over 200% Stock Upside – Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst In September, the FDA issued a Complete Response Letter to the company.